Cadrenal Therapeutics Inc (CVKD)

HC Wainwright Research Analysts Reduce Earnings Estimates for Cadrenal Therapeutics, Inc. (NASDAQ:CVKD) - Defense World

Defense World

Cadrenal Therapeutics' (CVKD) Buy Rating Reaffirmed at HC Wainwright - Defense World

Defense World

Cadrenal Therapeutics Highlights Presentation of New Trial Data at ISHLT Conference Demonstrating the Importance ... - PR Newswire

PR Newswire

Cadrenal Therapeutics to Participate in the Lytham Partners Spring 2024 Investor Conference on May 30, 2024 - PR Newswire

PR Newswire

Cadrenal Therapeutics to Participate in the Lytham Partners Spring 2024 Investor Conference on May 30, 2024 - PR Newswire

PR Newswire

Cadrenal Therapeutics to Participate in the Lytham Partners Spring 2024 Investor Conference on May 30, 2024 - Longview News-Journal

Longview News-Journal

Insider Buyers Lose Additional US$57k As Cadrenal Therapeutics Dips To US$7.0m - Simply Wall St

Simply Wall St

Insider Buyers Lose Additional US$57k As Cadrenal Therapeutics Dips To US$7.0m - Simply Wall St

Simply Wall St

Insider Buyers Lose Additional US$57k As Cadrenal Therapeutics Dips To US$7.0m - Simply Wall St

Simply Wall St

Cadrenal Therapeutics (NASDAQ:CVKD) Earns Buy Rating from HC Wainwright - Defense World

Defense World

Cadrenal Therapeutics Provides First Quarter 2024 Corporate Update - PR Newswire

PR Newswire

Cadrenal Therapeutics Provides First Quarter 2024 Corporate Update - Investing.com ZA - Investing.com South Africa

Investing.com South Africa

Cadrenal Therapeutics Provides First Quarter 2024 Corporate Update - PR Newswire

PR Newswire

Favourable Signals For Cadrenal Therapeutics: Numerous Insiders Acquired Stock - Yahoo Finance UK

Yahoo Finance UK

Analyzing Cadrenal Therapeutics (CVKD) & Its Peers - Defense World

Defense World

Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday - InvestorPlace

InvestorPlace

Cadrenal Therapeutics Gains FDA Orphan Drug Status for Tecarfarin - TipRanks

TipRanks

Cadrenal Therapeutics Receives FDA Orphan Drug Designation for Tecarfarin for Prevention of Thromboembolism and ... - PR Newswire

PR Newswire

Zura Bio Names Robert Lisicki as CEO & Director of the Board - Contract Pharma

Contract Pharma

Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday - InvestorPlace

InvestorPlace

Cadrenal Therapeutics Provides Fourth Quarter 2023 Corporate Update - PR Newswire

PR Newswire

Iambic hires Josephson as CMO - BioCentury

BioCentury

Why Compass Minerals International Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

Benzinga

Cadrenal Therapeutics Appoints Jeff Cole as Chief Operating Officer in Advance of Tecarfarin Phase 3 Pivotal Trial - PR Newswire

PR Newswire

Why 4D Molecular Therapeutics Shares Are Trading Higher By 20%; Here Are 20 Stocks Moving Premarket

Benzinga

Why 4D Molecular Therapeutics Shares Are Trading Higher By 20%; Here Are 20 Stocks Moving Premarket - Markets Insider

Markets Insider

Why Skechers Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session

Benzinga

Cadrenal Therapeutics Highlights Publication of Peer-Reviewed Article Supporting Need for New Anticoagulation ... - PR Newswire

PR Newswire

Here's Why We're Not Too Worried About Cadrenal Therapeutics' (NASDAQ:CVKD) Cash Burn Situation - Yahoo Finance

Yahoo Finance

Why Tellurian Shares Are Trading Higher By Over 16%; Here Are 20 Stocks Moving Premarket

Benzinga

Why Netflix Shares Are Trading Higher By 10%; Here Are 20 Stocks Moving Premarket

Benzinga

Thinking about buying stock in KE Holdings, Ford Motor, Vertiv Holdings, Cadrenal Therapeutics, or Aclaris ... - Marketscreener.com

Marketscreener.com

Thinking about buying stock in KE Holdings, Ford Motor, Vertiv Holdings, Cadrenal Therapeutics, or Aclaris ... - Marketscreener.com

Marketscreener.com

Why KeyCorp Shares Are Trading Lower By Over 5%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

Benzinga

Why M.D.C. Holdings Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket

Benzinga

Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday - InvestorPlace

InvestorPlace

Cadrenal Therapeutics to Present at the Biotech Showcase on January 8, 2024 Alongside the J.P. Morgan Annual ... - PR Newswire

PR Newswire

Noble Capital Markets Initiates Coverage on Cadrenal Therapeutics with Outperform Rating and US$4.00 Price Target - PR Newswire

PR Newswire

Why Lantheus Holdings Shares Are Trading Lower By Over 22%? Here Are Other Stocks Moving In Monday's Mid-Day Session

Benzinga

Why Lantheus Holdings Shares Are Trading Lower By Over 22%? Here Are Other Stocks Moving In Monday's Mid-Day ... - Markets Insider

Markets Insider

Cadrenal Therapeutics Engages The Sage Group to Advance Tecarfarin's Late-Stage Development and ... - PR Newswire

PR Newswire

Biopharma IPO class of 2023: Performance down 27% - BioWorld Online

BioWorld Online

Health Care Innovators: Cadrenal Therapeutics works to prevent heart attacks | Jax Daily Record - Jacksonville Daily Record

Jacksonville Daily Record

Cadrenal Therapeutics Highlights Additional Need for a New Vitamin K Antagonist (Tecarfarin) Following Updates from ... - PR Newswire

PR Newswire

Cadrenal Therapeutics Expands Evaluation of Tecarfarin for Patients with Antiphospholipid Syndrome (APS) - PR Newswire

PR Newswire

Why BYND Cannasoft Enterprises Shares Are Trading Lower By 40%; Here Are 20 Stocks Moving Premarket - Markets Insider

Markets Insider

Cadrenal Therapeutics Announces Closing of $7.5 Million Private Placement Priced At-the-Market under Nasdaq Rules - PR Newswire

PR Newswire

Cadrenal Therapeutics Announces $7.5 Million Private Placement Priced At-the-Market under Nasdaq Rules - PR Newswire

PR Newswire

Cadrenal celebrates IPO with bell ringing at Nasdaq - Jacksonville Business Journal - The Business Journals

The Business Journals

Cadrenal Therapeutics, With Deep OC Connections, Goes Public - Orange County Business Journal

Orange County Business Journal